(Q43531758)

English

Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection

scientific article published in February 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Wong WM

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Gu Q

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Chu KM

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Yee YK

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Fung FM

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Tong TS

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Chan AO

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Lai KC

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Chan CK

9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Wong BC

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

421-427

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy]

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Levofloxacin based regimens for the eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

13C-urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in Chinese

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02764.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2006.02764.X

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43531758&oldid=2098141291"